Time to start using newer oral anticoagulants for DVT-PE in cancer patients?
www.pulmccm.org
About one in five patients with cancer will develop pulmonary embolism (PE) or deep venous thrombosis (DVT), together called venous thromboembolism (VTE). Cancer patients who develop VTE are four times more likely to have experience another (recurrent) DVT or PE. Twice-daily injections of enoxaparin
Time to start using newer oral anticoagulants for DVT-PE in cancer patients?
Time to start using newer oral anticoagulants…
Time to start using newer oral anticoagulants for DVT-PE in cancer patients?
About one in five patients with cancer will develop pulmonary embolism (PE) or deep venous thrombosis (DVT), together called venous thromboembolism (VTE). Cancer patients who develop VTE are four times more likely to have experience another (recurrent) DVT or PE. Twice-daily injections of enoxaparin